Last reviewed · How we verify
continuous interscalene brachial plexus block — Competitive Intelligence Brief
Target snapshot
continuous interscalene brachial plexus block (continuous interscalene brachial plexus block) — Ciusss de L'Est de l'Île de Montréal. Delivers local anesthetic agents continuously to the brachial plexus nerve bundle, blocking sodium channels and preventing pain signal transmission.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| continuous interscalene brachial plexus block TARGET | continuous interscalene brachial plexus block | Ciusss de L'Est de l'Île de Montréal | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- continuous interscalene brachial plexus block CI watch — RSS
- continuous interscalene brachial plexus block CI watch — Atom
- continuous interscalene brachial plexus block CI watch — JSON
- continuous interscalene brachial plexus block alone — RSS
Cite this brief
Drug Landscape (2026). continuous interscalene brachial plexus block — Competitive Intelligence Brief. https://druglandscape.com/ci/continuous-interscalene-brachial-plexus-block. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing